Developing health policies in patients presenting with SARS-CoV-2: consider tuberculosis
The global pandemic of COVID-19 has led to a prominent public health response, with many countries introducing highly proactive measures for screening and identifying severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 has gained the dubious honour as the single greatest infectiou...
- Autores:
- Tipo de recurso:
- Article of investigation
- Fecha de publicación:
- 2020
- Institución:
- Universidad de Bogotá Jorge Tadeo Lozano
- Repositorio:
- Expeditio: repositorio UTadeo
- Idioma:
- eng
- OAI Identifier:
- oai:expeditiorepositorio.utadeo.edu.co:20.500.12010/14575
- Acceso en línea:
- https://doi.org/10.1016/S2214-109X(20)30413-7
http://hdl.handle.net/20.500.12010/14575
- Palabra clave:
- SARS-CoV-2
Health policies
Patients
Consider tuberculosis
Síndrome respiratorio agudo grave
COVID-19
SARS-CoV-2
Coronavirus
- Rights
- License
- Abierto (Texto Completo)
| Summary: | The global pandemic of COVID-19 has led to a prominent public health response, with many countries introducing highly proactive measures for screening and identifying severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 has gained the dubious honour as the single greatest infectious cause of global mortality in 2020. Active COVID-19 disease encompasses cough, fever, fatigue, and shortness of breath among other signs and symptoms.1,2 Risk factors for severe COVID-19 disease include diabetes, chronic obstructive pulmonary disease, immune suppression, and age. Some select population demographics (people who are Black, Hispanic, or a member of another ethnic minority group), in association with overcrowded housing and homelessness, are also at risk of severe disease and mortality |
|---|